Wharton Business Group LLC Invests $268,000 in Danaher Corporation (DHR)

Wharton Business Group LLC acquired a new position in Danaher Corporation (NYSE:DHR) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 3,122 shares of the conglomerate’s stock, valued at approximately $268,000.

Several other institutional investors and hedge funds also recently modified their holdings of the company. GQG Partners LLC acquired a new stake in Danaher Corporation during the 2nd quarter valued at $101,000. Proficio Capital Partners LLC boosted its position in Danaher Corporation by 92.3% in the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares during the last quarter. Monetary Management Group Inc. boosted its position in Danaher Corporation by 10.7% in the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after buying an additional 150 shares during the last quarter. Acrospire Investment Management LLC boosted its position in shares of Danaher Corporation by 185.5% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after purchasing an additional 1,100 shares during the last quarter. Finally, Motco boosted its position in shares of Danaher Corporation by 8.8% in the 2nd quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after purchasing an additional 163 shares during the last quarter. 75.56% of the stock is owned by institutional investors and hedge funds.

In other Danaher Corporation news, CFO Daniel L. Comas sold 88,184 shares of the company’s stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $91.02, for a total transaction of $8,026,507.68. Following the completion of the sale, the chief financial officer now directly owns 227,816 shares of the company’s stock, valued at $20,735,812.32. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider William King sold 43,688 shares of the stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the sale, the insider now directly owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The disclosure for this sale can be found here. In the last quarter, insiders sold 317,498 shares of company stock worth $28,838,801. Insiders own 12.20% of the company’s stock.

Danaher Corporation (DHR) opened at $94.18 on Wednesday. Danaher Corporation has a 52-week low of $76.27 and a 52-week high of $94.22. The stock has a market cap of $65,164.29, a PE ratio of 24.08, a price-to-earnings-growth ratio of 2.23 and a beta of 1.02. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The company had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. During the same quarter in the previous year, the company earned $0.87 earnings per share. Danaher Corporation’s quarterly revenue was up 9.6% on a year-over-year basis. equities research analysts expect that Danaher Corporation will post 3.99 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were paid a $0.14 dividend. The ex-dividend date was Thursday, September 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.59%. Danaher Corporation’s dividend payout ratio is presently 16.52%.

Several research analysts have weighed in on DHR shares. BidaskClub lowered Danaher Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 25th. Zacks Investment Research downgraded Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a research report on Friday, August 4th. J P Morgan Chase & Co reissued an “overweight” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, September 8th. Finally, Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and set a $83.00 price target on shares of Danaher Corporation in a research report on Tuesday, September 26th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. Danaher Corporation currently has an average rating of “Buy” and an average price target of $93.31.

ILLEGAL ACTIVITY WARNING: This piece was first published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.truebluetribune.com/2017/11/22/wharton-business-group-llc-invests-268000-in-danaher-corporation-dhr.html.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply